Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Adachi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceutics|May 4, 2026
Application of AI in Tablet Development: An Integrated Machine Learning Framework for Pre-Formulation Property PredictionMasugu Hamaguchi, Tomoki Adachi, Noriyoshi Arai
Current Developments in Nutrition|September 16, 2022
Pharmacokinetics of a Single Intake of a Self-Emulsifying Drug Delivery System Containing the Triglyceride Form of DHA: A Randomized, Double-Blinded, Crossover StudyMariko Hayashida, Yuri Ishii, Tomoki Adachi, et al.
Carbohydrate Polymers|December 6, 2020
The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseasesMakoto Anraku, Yasuyuki Mizukai, Yuji Maezaki, et al.
Carbohydrate Polymers|June 2, 2026
Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333]Tomoki Adachi, Nowshin Farzana Khan, Akihiro Michihara, et al.
Carbohydrate Research|November 16, 2024
The preparation and evaluation of granulated chitosan-catechin tablets with excellent disintegration propertiesTomoki Adachi, Yuto Tomita, Yasuyuki Mizukai, et al.
Carbohydrate Polymers|May 1, 2026
Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis ratsTomoki Adachi, Nowshin Farzana Khan, Akihiro Michihara, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceutics|May 4, 2026
Application of AI in Tablet Development: An Integrated Machine Learning Framework for Pre-Formulation Property PredictionMasugu Hamaguchi, Tomoki Adachi, Noriyoshi Arai
Current Developments in Nutrition|September 16, 2022
Pharmacokinetics of a Single Intake of a Self-Emulsifying Drug Delivery System Containing the Triglyceride Form of DHA: A Randomized, Double-Blinded, Crossover StudyMariko Hayashida, Yuri Ishii, Tomoki Adachi, et al.
Carbohydrate Polymers|December 6, 2020
The preparation and validation of chitosan tablets that rapidly disperse and disintegrate as an oral adsorbent in the treatment of lifestyle-related diseasesMakoto Anraku, Yasuyuki Mizukai, Yuji Maezaki, et al.
Carbohydrate Polymers|June 2, 2026
Corrigendum to "Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis rats" [Carbohydrate Polymers 383 (2026) 125333]Tomoki Adachi, Nowshin Farzana Khan, Akihiro Michihara, et al.
Carbohydrate Research|November 16, 2024
The preparation and evaluation of granulated chitosan-catechin tablets with excellent disintegration propertiesTomoki Adachi, Yuto Tomita, Yasuyuki Mizukai, et al.
Carbohydrate Polymers|May 1, 2026
Pharmaceutical optimization of chitosan tablets is associated with reduced circulating bile acids and fibrosis-related molecular signatures in non-alcoholic steatohepatitis ratsTomoki Adachi, Nowshin Farzana Khan, Akihiro Michihara, et al.
Pageof 1